PBLS
Parabilis Medicines, Inc.
32.60$
+4.4%
vs. previous close
Closing price · As of: Sep 28, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Parabilis Medicines, Inc. (PBLS) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/15/2026 | Current report (8-K) | Parabilis Medicines, Inc. (PBLS): Regulation FD Disclosure | View report ↗ |
| 09/02/2026 | Current report (8-K) | Parabilis Medicines, Inc. (PBLS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View report ↗ |
| 08/25/2026 | Current report (8-K) | Parabilis Medicines, Inc. (PBLS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/14/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/13/2026 | Current report (8-K) | Parabilis Medicines, Inc. (PBLS): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.